A dose intensity study of FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy and Escherichia coli-derived granulocyte-macrophage colony-stimulating factor (GM-CSF) in advanced breast cancer patients. [electronic resource]
Producer: 19950223Description: 709-16 p. digitalISSN:- 0923-7534
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- drug therapy
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Dyspnea -- etiology
- Escherichia coli
- Fluorouracil -- administration & dosage
- Granulocyte-Macrophage Colony-Stimulating Factor -- adverse effects
- Humans
- Hypotension -- etiology
- Leucovorin -- administration & dosage
- Middle Aged
- Neoplasm Staging
- Neutropenia -- chemically induced
- Recombinant Proteins -- adverse effects
- Regression Analysis
- Remission Induction
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.